A Dose Escalation Study of Ibrutinib with Lenalidomide for Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
2014; Elsevier BV; Volume: 124; Issue: 21 Linguagem: Inglês
10.1182/blood.v124.21.1987.1987
ISSN1528-0020
AutoresDaniel A. Pollyea, Steven Coutré, Lia Gore, Nichole Adler, Pamela Jo Harris, Mitch A. Phelps, Amy J. Johnson, Yonghua Ling, Hao Li, Jonathan A. Gutman, John C. Byrd,
Tópico(s)Chronic Myeloid Leukemia Treatments
Referência(s)